COMMUNIQUÉS West-GlobeNewswire

Fulcrum Therapeutics to Participate in Upcoming May Conferences

09/05/2024 - 14:00

CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]

PDS Biotech to Participate in Upcoming May 2024 Investor Conferences

09/05/2024 - 14:00

PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]

Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference

09/05/2024 - 14:00

MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel [...]

AEON Biopharma Provides Update on Development Pipeline

09/05/2024 - 14:00

Includes two late-stage clinical programs and two early-stage clinical programs IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage [...]

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.

09/05/2024 - 14:00

Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented [...]

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

09/05/2024 - 14:00

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over- [...]

Mounting Evidence that use of the Mental Health Collaborative Care Model is Associated with Reductions in Total Healthcare Costs

09/05/2024 - 13:48

Healthcare cost savings of 13% achieved under Collaborative Care Model versus treatment as usual WASHINGTON, May 09, 2024 (GLOBE NEWSWIRE) -- Lack of access to affordable and effective care for mental health and [...]

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

09/05/2024 - 13:45

- Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring valacyclovir and celecoxib (IMC-2) expected in the second-half of 2024 - - Conference Call Today at 8:30 a.m. [...]

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

09/05/2024 - 13:30

Initial Phase 2 data of BDTX-1535 in 2L/3L EGFRm NSCLC patients on track for Q3 2024 Enrollment ongoing in Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLC; initial data expected Q1 2025 [...]

Cronos Group Reports 2024 First Quarter Results

09/05/2024 - 13:30

Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach ® was top-3 in retail sales in Canada in the flower, edible, [...]

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

09/05/2024 - 13:30

- Completed SNS-101 monotherapy and combination dose escalation through 15mg/kg with no dose limiting toxicities - - Company to present topline clinical data from the SNS-101 Phase 1 dose escalation study at the 2024 [...]

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease

09/05/2024 - 13:30

MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today [...]

Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024

09/05/2024 - 13:30

THE WOODLANDS, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s [...]

Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults

09/05/2024 - 08:35

Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) notes that its partner Neurocrine Biosciences Inc. (“Neurocrine”; Nasdaq: NBIX), a leading neuroscience-focused [...]

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024

09/05/2024 - 08:30

Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2024 [...]

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

09/05/2024 - 07:00

BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 09 May 2024, 07:00 CEST Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting [...]

argenx Reports First Quarter 2024 Financial Results and Provides Business Update

09/05/2024 - 07:00

$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024 [...]

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

09/05/2024 - 03:15

ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success

09/05/2024 - 02:53

Announces Plan for $20 million in Aggregate New Financing to Support Daily Operations, Restructuring, Strategic Initiatives, and Advocacy Company Enters into Voluntary Chapter 11 Restructuring Process Which Will Take [...]